Rate My Professor Anders Sönnerborg

Anders Sönnerborg serves as Senior Professor in Infectious Diseases and Clinical Virology at the Department of Medicine, Huddinge, Karolinska Institutet, a role he took up in 2025 after serving as Professor in Infectious Diseases and Clinical Virology from 1998 to 2024. He was Head of the Division of Infectious Diseases, Department of Medicine Huddinge, from 2010 to 2024, and Head of the Division of Clinical Microbiology, Department of Laboratory Medicine, from 2012 to 2022. Sönnerborg has acted as senior consultant in the Department of Infectious Diseases at Karolinska University Hospital since 1993 and in the Department of Clinical Microbiology at Karolinska University Laboratory since 1991. He was appointed Docent at Karolinska Institutet in 1994 and held adjunct professorships in the Department of Laboratory Medicine from 2002 to 2011 and the Department of Medicine, Huddinge, from 2011 to 2012.

Sönnerborg leads the research group on translational research on human microbial infections and their consequences, studying pathogenesis, treatment, and control of viral and bacterial infections, particularly HIV-1. His investigations cover HIV reservoirs and cure strategies, antiretroviral therapy optimization, drug resistance, molecular epidemiology, microbiome influences on HIV-1 and SARS-CoV-2, antiviral development, and co-infections such as hepatitis C and tuberculosis/HIV. Key publications include "HIV-1 sub-subtype A6 remains susceptible to second-generation integrase inhibitors with limited emergence of resistance in vitro" (Open Forum Infectious Diseases, 2026), "Linking gut microbiome to HIV-1 reservoir size in people living with HIV" (Gut Pathogens, 2026), "Sweden surpasses the UNAIDS 95-95-95 target: estimating HIV-1 incidence, 2003 to 2022" (Eurosurveillance, 2024), "Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024" (Infectious Diseases, 2024), and "Long-term HIV-1 remission achieved through allogeneic hematopoietic stem cell transplantation" (Nature Microbiology, 2026). He supervises doctoral theses, secures grants from the Swedish Research Council, and contributes to cohorts like InfCareHIV, EuResist, and EuCARE, as well as national treatment guidelines.